Hypertension and the Heart (PW de Leeuw and AH Gradman, Section Editors)
Hypertension is associated with high mortality and morbidity that will increase if hypertension is left untreated. Treatment adherence is crucial in blood pressure control, and monitoring patient adherence is essential to the successful management of hypertension, since nonadherence is associated with poor prognosis. There are both direct and indirect methods to monitor adherence. Direct methods can be defined as assessment of treatment response or level of drug or its metabolite in blood, urine and body fluids without any intermediate or agent. Indirect methods require several instruments, such as questionnaires, reports, devices, and monitors. Certain methods may be advantageous in specific clinical and research settings. Advances in technology (new tools, devices, laboratory methods), and new approaches to reporting will not only help patients control high blood pressure but decrease hypertension-related mortality and morbidity.
This is a preview of subscription content, log in to check access.
Conflict of Interest
Serap Erdine declare that she has no conflict of interest.
Eren Arslan declare that he has no conflict of interest.
Papers of particular interest are highlighted as: • Of importance •• Of major importance
• Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–87. These updated, comprehensive guidelines for the management of arterial hypertension describe when to initiate treatment to a patient with high BP.PubMedCrossRefGoogle Scholar
Chisholm-Burns MA, Spivey CA. The “cost” of medication nonadherence: consequences we cannot afford to accept. J Am Pharm Assoc. 2012;52:823–6.CrossRefGoogle Scholar
Irvin MR, Shimbo D, Mann DM, Reynolds K, et al. Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension. J Clin Hypertens (Greenwich). 2012;14:694–700.CrossRefGoogle Scholar
Meichenbaum D, Turk DC. Faciliating treatment adherence: a practitioner’s guidebook. New York, NY: Plenum Press; 1987.CrossRefGoogle Scholar
Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther. 2006;28:1411–24.PubMedCrossRefGoogle Scholar
•• Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028–35. This reports extensively evaluated adherence to treatment from methods to measuring adherence to reasons of nonadherence to solutions for nonadherence.PubMedCrossRefGoogle Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97. This is a basic article on definitions of and factors related to medication adherence.PubMedCrossRefGoogle Scholar
Jung O, Gechter JL, Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31:766–74.PubMedCrossRefGoogle Scholar
WHO. Framework for effective tuberculosis control. WHO/TB/94.179. Geneva: World Health Organisation; 1994.Google Scholar
Charokopos N, Tsiros G, Foka A, et al. Modified directly observed treatment for tuberculosis versus self-administered therapy: an observational study inrural Greece. Rural Remote Heal. 2013;13:2114.Google Scholar
Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003). 2011;51:90–4.CrossRefGoogle Scholar
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–54.CrossRefGoogle Scholar
Korb-Savoldelli V, Gillaizeau F, Pouchot J, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens (Greenwich). 2012;14:429–34.CrossRefGoogle Scholar
Arnet I, Walter PN, Hersberger KE. Polymedication Electronic Monitoring System (POEMS) - a new technology for measuring adherence. Front Pharmacol. 2013;4:26.PubMedCrossRefGoogle Scholar
Hughes D. When drugs don't work: economic assessment of enhancing compliance with interventions supported by electronic monitoring devices. PharmacoEconomics. 2007;25:621–35.PubMedCrossRefGoogle Scholar
Haberer JE, Robbins GK, Ybarra M, et al. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012;16:375–82.PubMedCrossRefGoogle Scholar
• van Onzenoort HA, Verberk WJ, Kroon AA, et al. Electronic monitoring of adherence, treatment of hypertension, and blood pressure control. Am J Hypertens. 2012;25:54–9. This study showed that electronic monitoring was not associated with better long-term BP control.PubMedCrossRefGoogle Scholar
•• Ayoade A, Oladipo I. Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy. Blood Press. 2012;21:161–6. This article evaluates the correlation between a direct and indirect method of monitoring adherence. It must be an example for further studies on comparison between effectiveness of medication adherence measurement reports.PubMedCrossRefGoogle Scholar
Doró P, Benko R, Czakó A, et al. Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study. Int J Clin Pharm. 2011;33:690–5.PubMedCrossRefGoogle Scholar
Agarwal S, Lau CT. Remote health monitoring using mobile phones and Web services. Telemed J E Health. 2010;16(5):603–7.PubMedCrossRefGoogle Scholar